Research article · 6 Oct 2026
Conference abstractPublished 15 Apr 2013
Lipid metabolites derived from ω-3 long chain polyunsaturated fatty acids promote choroidal neovessel regression
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Age-related macular degeneration (AMD) is the primary cause of blindness in elderly individuals of industrialized countries, and has a projected 50% increase by the year 2020. There is an urgent need for new nutritional or pharmacological interventions that are safe over the long term for the treatment or prevention of AMD. Prospective clinical studies have suggested that dietary intake of ω-3 long-chain polyunsaturated fatty acids (LCPUFAs) may have a protective effect against AMD. Abnormal blood vessel growth (choroidal neovascularization (CNV)) is a hallmark of wet-AMD and leads to significant vision loss. This study sought to characterize the effects of dietary intake of ω-3 and ω-6 LCPUFAs in a mouse model of AMD. C57BL/6 mice were fed a diet enriched with either ω-3 or ω-6 LCPUFAs for 2 weeks. CNV was induced by photocoagulation using a 532-nm laser; and was evaluated by fluorescein angiography, optical coherence tomography, and choroidal flatmounts. Here we demonstrate that dietary supplementation of ω-3 LCPUFAs mediate choroidal neovessel regression. The serum lipid profiles in these mice promote the formation of anti-inflammatory eicosanoids and are enriched in DHA and EPA, the primary ω-3 LCPUFAs. Bioactive lipid metabolites, derived from ω-3 LCPUFAs, were identified as key mediators of disease resolution. Omega-3 LCPUFAs were also effective in dampening systemic inflammation and suppressed leukocyte recruitment to the disease site. A clear understanding of the mechanisms of these molecules in AMD could bring a major shift in our approach to disease treatment and prevention, since nutritional interventions are safe, inexpensive, and readily put into practice
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Experimental Ophthalmology.
Short communication · 30 Aug 2026
Vision Science in the Modern Era: Integrating Neuroscience, Genetics, and Technology
Commentary · 3 Aug 2026
Emerging Frontiers in Experimental Ophthalmology: Innovations and Translational Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Kip M Connor”
- BylineArticles whose byline prints “Ryoji Yanai”
- BylineArticles whose byline prints “Lama Mulki”
- BylineArticles whose byline prints “Harry Sweigard”
